Alere’s Device Recall Stirs More Questions About Abbott Deal

  • Abbott says it’s disappointed; review of deal continues
  • Analysts say financial filing from Alere expected by Friday

Alere Inc. is recalling a device that monitors patients taking a sensitive blood-thinning medicine, a move that may further destabilize its pending acquisition by Abbott Laboratories.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.